Viewing Study NCT06384560


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-02-28 @ 7:28 AM
Study NCT ID: NCT06384560
Status: RECRUITING
Last Update Posted: 2025-01-20
First Post: 2024-04-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Triple Treatment for Borderline Resectable Pancreatic Cancer (PREOPANC-5)
Sponsor: Amsterdam UMC, location VUmc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module